Cambria Investment Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Hold
2,682
– – 0.01% 720
2026
Q1
$231K Sell
2,682
-602
-18% -$54K 0.01% 603
2025
Q4
$287K Buy
+3,284
New +$249K 0.02% 518
2025
Q3
– Sell
-3,434
Closed -$203K – 545
2025
Q2
$203K Hold
3,434
– – 0.01% 425
2025
Q1
$251K Buy
+3,434
New +$284K 0.02% 327

Other funds holding GMED

Cambria Investment Management's GMED Position: Q2 2026 in Review

Cambria Investment Management held its Globus Medical (GMED) position steady in Q2 2026 at 2,682 shares worth $212K. The position accounts for 0.01% of the portfolio, ranked #720.

Cambria Investment Management first reported a position in GMED in Q1 2025 and has held it in 5 quarters since. The position peaked at $287K in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Cambria Investment Management held 2,682 shares of Globus Medical worth $212K as of Q2 2026.
  • Cambria Investment Management left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up 0.01% of Cambria Investment Management's portfolio in Q2 2026, its #720 holding.
  • Cambria Investment Management first reported a position in Globus Medical in Q1 2025 and has held it in 5 quarters since.
  • Cambria Investment Management's Globus Medical position peaked at $287K in Q4 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.